Retained products of conception, often abbreviated RPOC, refers to tissue that stays inside the uterus after a pregnancy ends. This tissue is usually from the placenta, though it can also include fetal or embryonic tissue. It can happen after a miscarriage, an abortion, a vaginal delivery, or a cesarean section. RPOC is one of the most common causes of bleeding after pregnancy, and it typically requires monitoring or treatment to avoid complications like infection.
What Tissue Gets Left Behind
During pregnancy, the placenta attaches to the uterine wall and serves as the lifeline between parent and baby. After delivery or pregnancy loss, the placenta and all associated tissue should be expelled or removed completely. When fragments remain attached to or lodged in the uterine lining, that’s RPOC. The retained tissue is most often placental, but pieces of the membrane that surrounded the pregnancy can also be involved.
The risk appears to increase with gestational age. RPOC occurs more frequently after second-trimester deliveries or terminations than after early first-trimester losses, likely because the placenta is larger and more firmly attached later in pregnancy.
Symptoms to Watch For
The three hallmark symptoms are abnormal vaginal bleeding, pelvic or abdominal pain, and fever. None of these is unique to RPOC, which is part of what makes it tricky to recognize. Bleeding might be heavier than expected after delivery or pregnancy loss, or it might taper off and then return days or weeks later. In one documented case, a woman experienced irregular vaginal bleeding that persisted for three months after her cesarean section before RPOC was identified.
Fever and worsening pain can signal that the retained tissue has become infected, a condition called endometritis. If you’re still bleeding more than expected several weeks after a pregnancy ends, or if bleeding seems to stop and then restarts, that pattern alone is worth bringing up with your provider.
How RPOC Is Diagnosed
Ultrasound is the primary tool. Doctors look for an echogenic mass (a bright, solid-looking area) inside the uterus or measure the thickness of the uterine lining. An endometrial thickness above 10 millimeters raises suspicion, with a sensitivity above 80% for detecting RPOC. However, seeing an actual mass on ultrasound is more accurate than thickness alone, with sensitivity ranging from 60% to 80% compared to just 7% for thickness measurements by themselves.
Doppler ultrasound, which shows blood flow, can add useful information. In one study, about 63% of patients with larger retained tissue (over 7 mm) showed active blood flow to the area on Doppler. Blood flow to the retained tissue generally means it’s still attached to the uterine wall and less likely to pass on its own.
A pregnancy hormone (hCG) blood test can also help. Levels that remain above non-pregnant thresholds more than four weeks after delivery suggest tissue may still be present. Very high levels can point to rarer conditions like a molar pregnancy, which requires different management.
Three Approaches to Treatment
Treatment falls into three categories: waiting it out, medication, or surgery. The right choice depends on how much tissue is retained, how much you’re bleeding, whether there are signs of infection, and whether the pregnancy ended through miscarriage, delivery, or termination.
Expectant Management
This means monitoring without active intervention, giving the body time to expel the tissue naturally. It works best for incomplete miscarriage, where some tissue has already passed. Success rates sit around 75%, but there’s a meaningful trade-off: up to 29% of women managed this way end up needing an emergency hospital visit, typically for heavy bleeding. In a study of women who waited after an initial procedure, the median time for hCG levels to return to normal was about 24 to 25 days, though it ranged widely from 9 to 88 days.
Medical Management
Medication can help the uterus contract and expel retained tissue. This approach uses hormones that soften the cervix and stimulate uterine contractions. For early pregnancy losses where the embryo stopped developing, a combination of two medications given a day or two apart is common. For incomplete miscarriage, medication doesn’t appear to offer a significant advantage over simply waiting, so it’s more often reserved for cases where the pregnancy stopped growing but tissue hasn’t started to pass.
Surgical Management
Surgery offers the highest rate of complete tissue removal and the shortest duration of bleeding afterward. It’s particularly relevant when there’s heavy bleeding, signs of infection, or when other approaches have failed. Two main procedures exist, and the difference between them matters significantly for future fertility.
The traditional approach, dilation and curettage (D&C), involves opening the cervix and using instruments to scrape tissue from the uterine wall. It’s effective but works somewhat blindly, since the surgeon can’t directly see inside the uterus. The newer alternative, hysteroscopic resection, uses a thin camera inserted through the cervix, allowing the surgeon to see the retained tissue and remove it precisely.
A study comparing the two in 177 women found striking differences in reproductive outcomes. Women who had hysteroscopic removal conceived again in an average of about 7 months, compared to nearly 13 months after D&C. New fertility problems, including blocked tubes and uterine scarring, developed in 24.5% of D&C patients versus 12% of those who had hysteroscopy. After adjusting for other factors, hysteroscopic resection cut the odds of developing a new fertility problem by more than half.
Complications of Untreated RPOC
Left in place, retained tissue creates three main risks. The first is hemorrhage. The uterus can’t fully contract and seal off its blood vessels while tissue is still attached, so bleeding can continue or suddenly worsen. The second is infection. Retained tissue is a breeding ground for bacteria, which can lead to endometritis and, in severe cases, sepsis (a life-threatening bloodstream infection). The third is scarring inside the uterus, known as Asherman syndrome, which can affect future fertility and menstrual cycles.
Asherman syndrome deserves special attention because it can also result from the treatment itself, not just the RPOC. D&C performed after a late miscarriage carries a roughly 30% risk of causing intrauterine adhesions. When a repeat procedure is needed two to four weeks after the first, the incidence climbs to about 23%. These adhesions can range from thin bands that cause no symptoms to dense scarring that blocks menstrual flow or prevents embryo implantation. This is a key reason hysteroscopic removal, with its lower adhesion rates, has become the preferred surgical option when available.
Recovery and What to Expect
After successful treatment, bleeding typically tapers off over one to two weeks, though some spotting can continue longer. Your provider will likely monitor hCG levels with periodic blood draws to confirm they’re dropping toward zero. Most women see levels normalize within three to four weeks, but it can take up to three months in some cases.
If you’re planning a future pregnancy, the method of treatment influences your timeline. After hysteroscopic removal, many women conceive within about seven months. After D&C, the average is closer to a year, partly because any adhesions that form may need additional treatment before conception is possible. Your provider may recommend a follow-up ultrasound or other imaging to confirm the uterus has returned to normal before you try to conceive again.